Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets closed
NZX 50
12,832.55
+12.27
(+0.10%)
NZD/USD
0.6158
-0.0026
(-0.41%)
NZD/EUR
0.5553
-0.0027
(-0.49%)
ALL ORDS
8,323.50
+30.40
(+0.37%)
ASX 200
8,099.90
+24.20
(+0.30%)
OIL
69.24
+0.27
(+0.39%)
BioLife Solutions, Inc. (BLFS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
25.12
+0.84
(+3.46%)
At close: 04:00PM EDT
25.12
0.00
(0.00%)
After hours:
05:08PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
154,805
143,271
161,759
119,156
48,087
-
Cost of revenue
108,789
96,519
107,937
82,108
20,646
-
Gross profit
46,016
46,752
53,822
37,048
27,441
-
Operating expenses
Research development
14,205
18,796
14,798
11,821
6,720
-
Selling general and administrative
64,879
80,308
69,240
47,674
21,686
-
Total operating expenses
90,182
104,285
93,735
67,697
31,439
-
Operating income or loss
-44,166
-57,533
-39,913
-30,649
-3,998
-
Interest expense
4
-
-
-
-
5
Total other income/expenses net
-67,116
-6,913
-104,227
2,108
2,677
-
Income before tax
-111,564
-66,258
-144,827
-29,026
-1,281
-
Income tax expense
-7,515
169
-5,022
-20,118
-3,264
-
Income from continuing operations
-104,049
-66,427
-139,805
-8,908
1,983
-
Net income
-104,049
-66,427
-139,805
-8,908
1,983
-
Net income available to common shareholders
-103,833
-66,427
-139,805
-8,908
1,983
-
Basic EPS
-2.37
-1.52
-3.29
-0.22
0.09
-
Diluted EPS
-2.37
-1.52
-3.29
-0.22
0.03
-
Basic average shares
43,210
43,719
42,481
38,504
27,306
-
Diluted average shares
43,210
43,719
42,481
38,504
27,306
-
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your privacy choices
About our ads
© 2024 Yahoo. All rights reserved.